Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $40.95 million. The enterprise value is $23.66 million.
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, before market open.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 5.76 million shares outstanding. The number of shares has increased by 40.71% in one year.
| Current Share Class | 5.76M |
| Shares Outstanding | 5.76M |
| Shares Change (YoY) | +40.71% |
| Shares Change (QoQ) | +21.54% |
| Owned by Insiders (%) | 2.23% |
| Owned by Institutions (%) | 47.65% |
| Float | 4.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| Forward PS | 0.58 |
| PB Ratio | -0.45 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.59
| Current Ratio | 0.59 |
| Quick Ratio | 0.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -45.03% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 899.61% |
| Revenue Per Employee | $446,396 |
| Profits Per Employee | -$591,822 |
| Employee Count | 225 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 17.54 |
Taxes
In the past 12 months, ATRA has paid $18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.16% in the last 52 weeks. The beta is 0.46, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -66.16% |
| 50-Day Moving Average | 10.64 |
| 200-Day Moving Average | 10.36 |
| Relative Strength Index (RSI) | 37.35 |
| Average Volume (20 Days) | 178,509 |
Short Selling Information
The latest short interest is 706,465, so 12.27% of the outstanding shares have been sold short.
| Short Interest | 706,465 |
| Short Previous Month | 547,760 |
| Short % of Shares Out | 12.27% |
| Short % of Float | 17.19% |
| Short Ratio (days to cover) | 1.64 |
Income Statement
In the last 12 months, ATRA had revenue of $100.44 million and -$133.16 million in losses. Loss per share was -$22.60.
| Revenue | 100.44M |
| Gross Profit | -79.93M |
| Operating Income | -119.41M |
| Pretax Income | -233.09M |
| Net Income | -133.16M |
| EBITDA | -114.25M |
| EBIT | -119.41M |
| Loss Per Share | -$22.60 |
Full Income StatementBalance Sheet
The company has $67.19 million in cash and $49.90 million in debt, giving a net cash position of $17.29 million or $3.00 per share.
| Cash & Cash Equivalents | 67.19M |
| Total Debt | 49.90M |
| Net Cash | 17.29M |
| Net Cash Per Share | $3.00 |
| Equity (Book Value) | -90.54M |
| Book Value Per Share | -15.77 |
| Working Capital | -64.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$94.65 million and capital expenditures -$200,000, giving a free cash flow of -$94.85 million.
| Operating Cash Flow | -94.65M |
| Capital Expenditures | -200,000 |
| Free Cash Flow | -94.85M |
| FCF Per Share | -$16.47 |
Full Cash Flow StatementMargins
Gross margin is -79.58%, with operating and profit margins of -118.88% and -132.58%.
| Gross Margin | -79.58% |
| Operating Margin | -118.88% |
| Pretax Margin | -132.56% |
| Profit Margin | -132.58% |
| EBITDA Margin | -113.75% |
| EBIT Margin | -118.88% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.71% |
| Shareholder Yield | -40.71% |
| Earnings Yield | -325.16% |
| FCF Yield | -231.62% |
Analyst Forecast
The average price target for ATRA is $25.70, which is 261.46% higher than the current price. The consensus rating is "Buy".
| Price Target | $25.70 |
| Price Target Difference | 261.46% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 67.71% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04:1.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04:1 |
Scores
ATRA has an Altman Z-Score of -22.45 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.45 |
| Piotroski F-Score | 3 |